Damien Mcdevitt - Net Worth and Insider Trading

Damien Mcdevitt Net Worth

The estimated net worth of Damien Mcdevitt is at least $4 Million dollars as of 2024-05-08. Damien Mcdevitt is the CEO of Akcea Therapeutics Inc and owns about 242,978 shares of Akcea Therapeutics Inc (AKCA) stock worth over $4 Million. Details can be seen in Damien Mcdevitt's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Damien Mcdevitt has not made any transactions after 2020-09-22 and currently still holds the listed stock(s).

Transaction Summary of Damien Mcdevitt

To

Damien Mcdevitt Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Damien Mcdevitt owns 2 companies in total, including Akcea Therapeutics Inc (AKCA) , and Ionis Pharmaceuticals Inc (IONS) .

Click here to see the complete history of Damien Mcdevitt’s form 4 insider trades.

Insider Ownership Summary of Damien Mcdevitt

Ticker Comapny Transaction Date Type of Owner
AKCA Akcea Therapeutics Inc 2020-10-12 director & Chief Executive Officer
IONS Ionis Pharmaceuticals Inc 2018-06-18 Chief Business Officer

Damien Mcdevitt Latest Holdings Summary

Damien Mcdevitt currently owns a total of 1 stock. Damien Mcdevitt owns 242,978 shares of Akcea Therapeutics Inc (AKCA) as of September 22, 2020, with a value of $4 Million.

Latest Holdings of Damien Mcdevitt

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AKCA Akcea Therapeutics Inc 2020-09-22 242,978 18.17 4,414,910

Holding Weightings of Damien Mcdevitt


Damien Mcdevitt Form 4 Trading Tracker

According to the SEC Form 4 filings, Damien Mcdevitt has made a total of 2 transactions in Akcea Therapeutics Inc (AKCA) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Akcea Therapeutics Inc is the sale of 8,709 shares on September 22, 2020, which brought Damien Mcdevitt around $157,807.

Insider Trading History of Damien Mcdevitt

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Damien Mcdevitt Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Damien Mcdevitt Ownership Network

Ownership Network List of Damien Mcdevitt

No Data

Ownership Network Relation of Damien Mcdevitt


Damien Mcdevitt Owned Company Details

What does Akcea Therapeutics Inc do?

Who are the key executives at Akcea Therapeutics Inc?

Damien Mcdevitt is the director & Chief Executive Officer of Akcea Therapeutics Inc. Other key executives at Akcea Therapeutics Inc include Chief Medical Officer William T. Andrews , Chief Financial Officer Michael Dennis Price , and Chief Commercial Officer Kyle Jenne .

Akcea Therapeutics Inc (AKCA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Akcea Therapeutics Inc (AKCA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Akcea Therapeutics Inc (AKCA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Akcea Therapeutics Inc (AKCA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Akcea Therapeutics Inc Insider Transactions

No Available Data

Damien Mcdevitt Mailing Address

Above is the net worth, insider trading, and ownership report for Damien Mcdevitt. You might contact Damien Mcdevitt via mailing address: C/o Ionis Pharmaceuticals, Inc., 2855 Gazelle Court, Carlsbad Ca 92010.

Discussions on Damien Mcdevitt

No discussions yet.